Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway

被引：0
|
作者：
Wei Han
Nan Wang
Rui Kong
Wen Bao
Jie Lu
机构：
[1] Tongji University School of Medicine,Department of Gastroenterology, Shanghai Tenth People’s Hospital
[2] Gongli Hospital of Shanghai Pudong New Area,Department of Gastroenterology
来源：
Journal of Translational Medicine | / 20卷
关键词：
PPARδ; HCC; Prognosis; PI3K-AKT;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway
    Han, Wei
    Wang, Nan
    Kong, Rui
    Bao, Wen
    Lu, Jie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
  • [2] ARHGAP20 Expression Inhibited HCC Progression by Regulating the PI3K-AKT Signaling Pathway
    Liu, Gao
    Li, Jia
    Zhang, Cai-Yun
    Huang, Dong-Yang
    Xu, Ji-Wei
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 271 - 284
  • [3] LncRNA TMPO-AS1 promotes hepatocellular carcinoma progression via activating PI3K-AKT pathway
    Ye, Huan
    Zhang, Chenchen
    Li, Zhengcai
    MINERVA GASTROENTEROLOGY, 2022, 68 (03): : 344 - 344
  • [4] Osteopontin promotes hepatocellular carcinoma progression via the PI3K/AKT/Twist signaling pathway
    Yu, Xinxin
    Zheng, Yan
    Zhu, Xuchao
    Gao, Xiaomei
    Wang, Chaoqun
    Sheng, Yuanyuan
    Cheng, Wei
    Qin, Lunxiu
    Ren, Ning
    Jia, Huliang
    Dong, Qiongzhu
    ONCOLOGY LETTERS, 2018, 16 (04) : 5299 - 5308
  • [5] Midkine promotes glioblastoma progression via PI3K-Akt signaling
    Beiquan Hu
    Chao Qin
    Li Li
    Lei Wei
    Xianlun Mo
    Huasheng Fan
    Yuanhua Lei
    Feng Wei
    Donghua Zou
    Cancer Cell International, 21
  • [6] Midkine promotes glioblastoma progression via PI3K-Akt signaling
    Hu, Beiquan
    Qin, Chao
    Li, Li
    Wei, Lei
    Mo, Xianlun
    Fan, Huasheng
    Lei, Yuanhua
    Wei, Feng
    Zou, Donghua
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [7] Tanshinol inhibits the growth, migration and invasion of hepatocellular carcinoma cells via regulating the PI3K-AKT signaling pathway
    Zhu, Pingting
    Liu, Zhaoguo
    Zhou, JiaoJiao
    Chen, Yuanyuan
    ONCOTARGETS AND THERAPY, 2019, 12 : 87 - 99
  • [8] Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K-AKT signaling pathway
    Qiao, Zhongshi
    Dai, Chengcheng
    Wang, Zhiqian
    Wang, Zifan
    Wang, Zheng
    Zhang, Tongsong
    Niu, Wenjing
    Ma, Xuezhen
    THORACIC CANCER, 2022, 13 (08) : 1117 - 1125
  • [9] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Ye, Yanqing
    Liu, Maosheng
    Wu, Fengfei
    Ou, Shiyu
    Wang, Weidong
    Fei, Jieying
    Xie, Fang
    Bai, Lan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [10] TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
    Yanqing Ye
    Maosheng Liu
    Fengfei Wu
    Shiyu Ou
    Weidong Wang
    Jieying Fei
    Fang Xie
    Lan Bai
    European Journal of Medical Research, 28
12345